NCT07435246

Brief Summary

This randomized controlled study aims to evaluate the effects of acupressure on quality of life, sleep quality, and hopelessness levels in older adults living in a nursing home setting. Aging is associated with decreased sleep quality, reduced life satisfaction, and increased psychological distress, including hopelessness. Non-pharmacological and low-risk interventions are increasingly needed to improve well-being in older populations. In this study, 50 participants aged 65 years and older were randomly assigned to either an intervention group (acupressure) or a control group (no intervention). The intervention group received acupressure applied to Shenmen (HT7), Neiguan (P6), and Sanyinjiao (SP6) points three times per week for four weeks. The control group received routine care without additional intervention. Outcomes were measured before and after the intervention using the CASP-19 Quality of Life Scale, the Richard-Campbell Sleep Questionnaire, and the Beck Hopelessness Scale. The study evaluates whether acupressure can serve as a safe and effective complementary nursing intervention to improve sleep and overall well-being in older adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

9 months

First QC Date

February 20, 2026

Last Update Submit

February 20, 2026

Conditions

Keywords

AcupressureOlder AdultsSleep QualityQuality of LifeHopelessness

Outcome Measures

Primary Outcomes (1)

  • Change in Sleep Quality Score

    Sleep quality was assessed using the Richard-Campbell Sleep Questionnaire (RCSQ). The total score ranges from 0 to 100, with higher scores indicating better sleep quality. The primary endpoint was the change in total score from baseline to week 4.

    Baseline (Week 0) and Week 4

Secondary Outcomes (1)

  • Change in Quality of Life Score

    Baseline (Week 0) and Week 4

Study Arms (2)

Acupressure Group

EXPERIMENTAL

Participants received manual acupressure applied to Shenmen (HT7), Neiguan (P6), and Sanyinjiao (SP6) points three times per week for four weeks in addition to routine care.

Other: Acupressure

Control Group

NO INTERVENTION

Participants received routine institutional care without additional intervention during the study period.

Interventions

Manual acupressure was applied bilaterally to HT7, P6, and SP6 points. Each point was stimulated for approximately two minutes per session. The intervention was administered three times weekly for four consecutive weeks by a trained researcher.

Acupressure Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Aged 65 years or older
  • Residing in the nursing home where the study was conducted
  • Able to communicate verbally
  • Able to read and understand the questionnaires
  • Volunteered to participate in the study

You may not qualify if:

  • Presence of skin lesions, wounds, or infection at acupressure points
  • Diagnosed cognitive impairment preventing questionnaire completion
  • Severe hearing or communication problems
  • Receiving another complementary therapy during the study period
  • Refusal to continue participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kafkas University

Kars, Turkey (Türkiye)

Location

MeSH Terms

Conditions

ParasomniasSleep Initiation and Maintenance Disorders

Interventions

Acupressure

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersSleep Disorders, IntrinsicDyssomnias

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The statistician who analyzed the data was blinded to group allocation. Participants were not informed about group assignment during data collection.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, parallel-group controlled study with two arms (acupressure intervention and routine care control group). Participants were assigned in a 1:1 ratio.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 20, 2026

First Posted

February 27, 2026

Study Start

September 1, 2024

Primary Completion

May 30, 2025

Study Completion

May 30, 2025

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) will be shared, including baseline demographic characteristics (age, sex), group allocation, and outcome measure scores (Richard-Campbell Sleep Questionnaire, CASP-19 Quality of Life Scale, and Beck Hopelessness Scale) collected at baseline and at week 4. No personally identifiable information will be included in the shared dataset.

Shared Documents
STUDY PROTOCOL
Time Frame
Individual participant data will be available beginning 6 months after publication of the study results and ending 5 years after publication.
Access Criteria
Access to de-identified individual participant data, study protocol, statistical analysis plan, and analytic code will be granted to researchers who provide a methodologically sound research proposal. Requests should be directed to the corresponding author. Data will be shared after approval by the study investigators and signing of a data use agreement. Data will be provided in electronic format.

Locations